| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Neoplasia (Imaging)Neoplasia (Carcinogenesis)MRT (Instrumentation)Neoplasia (MRT)Neoplasia (PET)MRT (DCE MRI)Vaccine (Oncology)Neoplasia (Classification and staging)Radioimmunotherapy and radioligandtherapy| 1 | 2008 | New technologies for human cancer imaging. | 
| + | - | nl | J Clin Oncol 26(24):4012-21 (2008) |
| 2 | 2006 | Tumor hypoxia imaging. | 
| + | - | nl | Clin Cancer Res 12(18):5260-4 (2006) |
| 3 | 2008 | Imaging and cancer: a review. | 
| + | - | nl | Mol Oncol 2(2):115-52 (2008) |
| 4 | 2009 | Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers. | 
| + | - | nl | J Nucl Med 50(2):239-49 (2009) |
| 5 | 2008 | Noninvasive imaging of cell-mediated therapy for treatment of cancer. | 
| + | - | nl | J Nucl Med 49 Suppl 2(-):180S-95S (2008) |
| 6 | 2008 | Radiologic measurements of tumor response to treatment: practical approaches and limitations. | 
| + | - | nl | Radiographics 28(2):329-44 (2008) |
| 7 | 2003 | Second malignancies in pediatric patients: imaging findings and differential diagnosis. | 
| + | - | nl | Radiographics 23(5):1155-72 (2003) |
| 8 | 2008 | Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelines. | 
| + | - | nl | Br J Radiol 81(966):444-9 (2008) |
| 9 | 2003 | Response evaluation criteria in solid tumours (RECIST): problems and need for modifications in paediatric oncology? | 
| + | - | nl | Br J Radiol 76(907):433-6 (2003) |
| 10 | 2002 | Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria. | 
| + | - | nl | Br J Radiol 75(899):903-8 (2002) |
| 11 | 1997 | Assessment of response following treatment for malignant disease. | 
| + | - | nl | Br J Radiol 70 Spec No(-):S41-9 (1997) |
| 12 | 2000 | Body CT and oncologic imaging. | 
| + | - | nl | Radiology 215(1):27-40 (2000) |
| 13 | 2010 | Identification, biopsy, and treatment of poorly understood premalignant, in situ, and indolent low-grade cancers: are we becoming victims of our own success? | 
| + | - | nl | Radiology 254(3):655-9 (2010) |
| 14 | 2005 | Molecular imaging of antiangiogenic agents. | 
| + | - | nl | Oncologist 10(2):92-103 (2005) |
| 15 | 2010 | Imaging in radiation oncology: a perspective. | 
| + | - | nl | Oncologist 15(4):338-49 (2010) |
| 16 | 2008 | Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow. | 
| + | - | nl | Oncologist 13(6):631-44 (2008) |
| 17 | 2010 | Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities. | 
| + | - | nl | Cancer Res 70(15):6109-13 (2010) |
| 18 | 2009 | State-of-the-art imaging for detecting cancer in the clinic. | 
| + | - | nl | Future Oncol 5(2):135-9 (2009) |
| 19 | 2009 | Imaging of the unusual pediatric 'blastomas'. | 
| + | - | nl | Cancer Imaging 9(-):1-11 (2009) |
| 20 | 2008 | Warburg revisited: imaging tumour blood flow and metabolism. | 
| + | - | nl | Cancer Imaging 8(-):81-6 (2008) |
| 21 | 2007 | Nuclear imaging in cancer theranostics. | 
| + | - | nl | Q J Nucl Med Mol Imaging 51(2):152-63 (2007) |